2018
BMC public health, (2018).18 1 10.1186/s12889-018-6228-5.
2018
TUBERCULOSIS, (2018).113, 10.1016/j.tube.2018.08.013.
2018
LANCET GLOBAL HEALTH, (2018).6 12 10.1016/S2214-109X(18)30383-8.
2018
JOURNAL OF IMMUNOLOGY RESEARCH, (2018).2018, 10.1155/2018/8087916.
A Dose Reduction Immunobridging and Safety Study of Two Human Papillomavirus Vaccines in Tanzanian Girls (DoRIS): Enrolment and Progress to Date.
2018
(2018).
2018
Vaccine, (2018).37 2 10.1016/j.vaccine.2018.10.077.
2018
Lancet (London, England), (2018).392 10161 10.1016/s0140-6736(18)32608-4.
2018
Vaccine, (2018).35 45 10.1016/j.vaccine.2017.09.073.
2018
The Pediatric infectious disease journal, (2018).38 6 10.1097/INF.0000000000002242.
